Tech Company Financing Transactions

Avidity Biosciences Funding Round

On 10/18/2018, Avidity Biosciences raised investment from CureDuchenne Ventures.

Transaction Overview

Announced On
10/18/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors

CureDuchenne Ventures (Debra Miller)

Proceeds Purpose
Funding will help to advance pre-clinical development of potential therapies to treat patients with Duchenne muscular dystrophy (DMD).

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10975 North Torrey Pines Rd. 150
La Jolla, CA 92037
USA
Email Address
Overview
Avidity Biosciences LLC offers research, development, and manufacturing of drug candidates which include antibody-siRNA complexes.
Profile
Avidity Biosciences LinkedIn Company Profile
Social Media
Avidity Biosciences Company Twitter Account
Company News
Avidity Biosciences News
Facebook
Avidity Biosciences on Facebook
YouTube
Avidity Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
Troy Wilson
  Troy Wilson LinkedIn Profile  Troy Wilson Twitter Account  Troy Wilson News  Troy Wilson on Facebook
Chief Executive Officer
Sarah Boyce
  Sarah Boyce LinkedIn Profile  Sarah Boyce Twitter Account  Sarah Boyce News  Sarah Boyce on Facebook
Chief Scientific Officer
Arthur Levin
  Arthur Levin LinkedIn Profile  Arthur Levin Twitter Account  Arthur Levin News  Arthur Levin on Facebook
Vice President
Andrew Geall
  Andrew Geall LinkedIn Profile  Andrew Geall Twitter Account  Andrew Geall News  Andrew Geall on Facebook
Vice President
John Wallen
  John Wallen LinkedIn Profile  John Wallen Twitter Account  John Wallen News  John Wallen on Facebook
VP - Bus. Development
Kent Hawryluk
  Kent Hawryluk LinkedIn Profile  Kent Hawryluk Twitter Account  Kent Hawryluk News  Kent Hawryluk on Facebook
VP - Finance
Vanessa Jacoby
  Vanessa Jacoby LinkedIn Profile  Vanessa Jacoby Twitter Account  Vanessa Jacoby News  Vanessa Jacoby on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/18/2018: Oh My Green venture capital transaction
Next: 10/18/2018: BidMySmile venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary